Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WMG who wrote (3126)	12/4/1997 12:16:00 AM
From: JOHN W.	Read Replies (1) of 6136

MRI Documents Reversal Of AIDS Dementia With Protease Inhibitors CHICAGO, Dec 03 (Reuters) - At the 83rd Scientific Assembly and Annual Meeting of the Radiological Society of North America, researchers presented new evidence that protease inhibitors can halt the progression of HIV-encephalopathy. The study is the first to demonstrate the impact of the new HIV drugs on AIDS dementia, said study co-author Dr. Christopher G. Filippi, assistant professor of radiology and director of neuroradiology at Weiler Hospital, Albert Einstein College of Medicine, New York. Magnetic resonance imaging scans of 16 AIDS patients showed that of nine who received protease inhibitors, four showed stabilization of HIV-encephalopathy, four showed near complete regression and one showed slight progression. Six of seven patients not on protease inhibitors showed progression, and one exhibited no change.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next